JP2016518415A - 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法 - Google Patents

加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法 Download PDF

Info

Publication number
JP2016518415A
JP2016518415A JP2016513120A JP2016513120A JP2016518415A JP 2016518415 A JP2016518415 A JP 2016518415A JP 2016513120 A JP2016513120 A JP 2016513120A JP 2016513120 A JP2016513120 A JP 2016513120A JP 2016518415 A JP2016518415 A JP 2016518415A
Authority
JP
Japan
Prior art keywords
stem cell
csf
patient
aging
months
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016513120A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016518415A5 (enExample
Inventor
ディップナリン マハラージ
ディップナリン マハラージ
Original Assignee
アドバンスド ニューロリジェネレイティブ セラピーズ エルエルシー
アドバンスド ニューロリジェネレイティブ セラピーズ エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アドバンスド ニューロリジェネレイティブ セラピーズ エルエルシー, アドバンスド ニューロリジェネレイティブ セラピーズ エルエルシー filed Critical アドバンスド ニューロリジェネレイティブ セラピーズ エルエルシー
Priority claimed from PCT/US2014/037496 external-priority patent/WO2014183033A2/en
Publication of JP2016518415A publication Critical patent/JP2016518415A/ja
Publication of JP2016518415A5 publication Critical patent/JP2016518415A5/ja
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2016513120A 2013-10-21 2014-05-09 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法 Pending JP2016518415A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361893444P 2013-10-21 2013-10-21
US61/893,444 2013-10-21
PCT/US2014/037496 WO2014183033A2 (en) 2013-05-09 2014-05-09 Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019059259A Division JP2019112463A (ja) 2013-10-21 2019-03-26 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法

Publications (2)

Publication Number Publication Date
JP2016518415A true JP2016518415A (ja) 2016-06-23
JP2016518415A5 JP2016518415A5 (enExample) 2017-06-15

Family

ID=56142414

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016513120A Pending JP2016518415A (ja) 2013-10-21 2014-05-09 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
JP2019059259A Pending JP2019112463A (ja) 2013-10-21 2019-03-26 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
JP2021024199A Active JP7642278B2 (ja) 2013-10-21 2021-02-18 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019059259A Pending JP2019112463A (ja) 2013-10-21 2019-03-26 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
JP2021024199A Active JP7642278B2 (ja) 2013-10-21 2021-02-18 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法

Country Status (1)

Country Link
JP (3) JP2016518415A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110743103A (zh) * 2019-10-25 2020-02-04 上海市同济医院 一种促进脊髓来源神经干细胞修复损伤的磁场干预装置及方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050267355A1 (en) * 2004-05-27 2005-12-01 Parker Richard F Method and apparatus for generating a therapeutic magetic field
JP2007512814A (ja) * 2003-11-24 2007-05-24 ノースウエスト バイオセラピューティクス，インコーポレイティド 接線流れ濾過デバイス、および幹細胞富化のための方法
JP2008531051A (ja) * 2005-02-28 2008-08-14 リジェネテック，インコーポレイテッド すぐに利用できる末梢血由来の細胞物質を提供する方法およびその組成

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427747B1 (en) * 2001-08-30 2012-04-11 ARCA biopharma, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
JP2007105037A (ja) * 2005-09-16 2007-04-26 Univ Of Tokyo キメリズムを利用した幹細胞移植のための検査
KR101493474B1 (ko) * 2007-01-09 2015-02-16 클리브랜드 바이오랩스, 아이엔씨. 조혈 줄기 세포를 증가시키고 이동시키는 방법들

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512814A (ja) * 2003-11-24 2007-05-24 ノースウエスト バイオセラピューティクス，インコーポレイティド 接線流れ濾過デバイス、および幹細胞富化のための方法
US20050267355A1 (en) * 2004-05-27 2005-12-01 Parker Richard F Method and apparatus for generating a therapeutic magetic field
JP2008531051A (ja) * 2005-02-28 2008-08-14 リジェネテック，インコーポレイテッド すぐに利用できる末梢血由来の細胞物質を提供する方法およびその組成

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110743103A (zh) * 2019-10-25 2020-02-04 上海市同济医院 一种促进脊髓来源神经干细胞修复损伤的磁场干预装置及方法

Also Published As

Publication number Publication date
JP7642278B2 (ja) 2025-03-10
JP2021075574A (ja) 2021-05-20
JP2019112463A (ja) 2019-07-11

Similar Documents

Publication Publication Date Title
US20250170411A1 (en) Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use
US20210069503A1 (en) Methods for Reducing Viability of Cancer Cells by Activation of the STING Pathway with TTFields
Mukhamedshina et al. Mesenchymal stem cell therapy for spinal cord contusion: a comparative study on small and large animal models
Olin et al. Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4+ IL17+ response
Buetefisch et al. Neuroprotection of Low‐Frequency Repetitive Transcranial Magnetic Stimulation After Ischemic Stroke in Rats
JP5809068B2 (ja) 免疫抑制−関連疾患の治療
Krueger et al. Effects of low-intensity electrical stimulation and adipose derived stem cells transplantation on the time-domain analysis-based electromyographic signals in dogs with SCI
Zhang The role of mesenchymal stem cells in modulating the breast Cancer Microenvironment
KR20170124467A (ko) 저산소 조건을 이용한 면역세포의 증식 배양 방법
JP7642278B2 (ja) 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
ES2789574T3 (es) Modulación de la activación del inflamasoma de células supresoras derivadas de mieloides para el tratamiento de GvHD o tumor
Yu et al. Efficacy of Human Umbilical Cord Blood‐Mononuclear Cell Transplantation for MSA Treatment and Its Effects on Changes in T‐Cell Subsets in Peripheral Blood and Inflammatory Factors
Aboushady et al. The effect of transplanted bone marrow stem cells on the tongue of irradiated rats (Histological and Immunohistochemical study)
BRPI0717150A2 (pt) Células-tronco mesenquimais e usos para as mesmas
Erie et al. MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure
Naeem et al. Focusing on the cytokine storm in the battle against COVID-19: the rising role of mesenchymal-derived stem cells
Okada IL-3 NOVEL SYNNOTCH-CAR-BASED T-CELL THERAPY FOR BRAIN TUMORS
Gorenkova et al. Potentials of brentuximab vedotin in the treatment of relapse/refractory cutaneous T-cell lymphomas: literature review and authors’ observation
CN120936370A (zh) 用于使用肿瘤治疗电场和杀伤细胞治疗癌症的组合物、系统和方法
Carinci et al. SIDE EFFECTS OF STATINS, INCLUDING NEUROLOGICAL DISORDERS: NEW ADVANCES
CN119769469A (zh) 一种具有nk细胞分化的人源化免疫重建动物模型的构建方法和应用
RU2564114C1 (ru) Индуктор il-12 и il-1a
KR20200144060A (ko) 건강한 사람의 면역세포 배양액을 이용한 nk 세포의 함량을 증진시키는 방법
Acton Advances in Immune System Research and Application: 2012 Edition
Stepien et al. Research Article Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20160324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170424

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180426

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180625

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180731

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181127